ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10318
Vaccine NameCovidful
Disease NameCOVID-19
Disease ClassificationRespiratory
Virus NameSARS-CoV-2 virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypeLive-attenuated
Vaccine StatusPhase 3
ManufacturerChinese Academy of Medical Sciences
Year of Manufacturing2021
Manufacturing CountryChina
Age18 years and above
Dosage2 doses 2 weeks apart
Administration RouteIntramuscular
AdjuvantNA
Target StrainNA
DescriptionNA
Approving OrganisationNA
Collaborating OrganisationInstitute of Medical Biology
Other CountriesBrazil, Malaysia
Trade NameIMBCAMS COVID-19 vaccine
PMIDNA
Clinical Trial IDNCT04659239
Reference Linkhttps://clinicaltrials.gov/show/NCT04659239
Additional Linkshttps://clinicaltrials.gov/ct2/show/NCT05164731